Evidence map›Paper›PMID 30185168›Full record

ArticleBMC infectious diseases2018

Relapse of chronic melioidosis in a paediatric cystic fibrosis patient: first case report from Malaysia.

Vanitha Mariappan, Surendran Thavagnanam, Kumutha Malar Vellasamy, Cindy Ju Shuan Teh, Nadia Atiya, Sasheela Ponnampalavanar, Jamuna Vadivelu

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Vanitha MariappanDepartment of Medical Microbiology Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. vanitha.ma@gmail.com.ORCID http://orcid.org/0000-0002-2351-1597
Surendran ThavagnanamUniversity Malaya Pediatric and Child Health Research Group, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
Kumutha Malar VellasamyDepartment of Medical Microbiology Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
Cindy Ju Shuan TehDepartment of Medical Microbiology Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
Nadia AtiyaDepartment of Medical Microbiology Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
Sasheela PonnampalavanarDepartment of Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia.
Jamuna VadiveluDepartment of Medical Microbiology Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. jamuna@ummc.edu.my.
University Malaya Medical Centre · MYUniversity of Malaya · MY

Funding

Ministry of Higher Education (MOHE), Malaysia under the High Impact Research (HIR)-MOHE E000013-20001University of Malaya Research Grant (UMRG) RP013C-13HTM
6 · The paper itself

Abstract

backgroundBurkholderia pseudomallei is the causative agent of melioidosis, which is a potentially life threatening disease endemic in Southeast Asian countries. In Malaysia, cystic fibrosis (CF) is an uncommon condition. The association between CF and B.pseudomallei infections has been reported previously. However, this is the first case report of a pediatric melioidosis relapse and co-infection with other Gram-negative bacteria in Malaysia. CASE PRESENTATION: A 14-year-old Chinese Malaysian boy presented with a history of recurrent pneumonia, poor growth and steatorrhoea since childhood, and was diagnosed with CF. B. pseudomallei was cultured from his sputum during three different admissions between 2013 and 2016. However, the patient succumbed to end stage of respiratory failure in 2017 despite antibiotics treatment against B.pseudomallei. The isolates were compared using multilocus-sequence typing and repetitive-element polymerase chain reaction (PCR), and confirmed that two of the isolates were of same sequence type, which may indicate relapse.

conclusionsCF patients should be aware of melioidosis in endemic regions, as it is an emerging infectious disease, especially when persistent or recurrent respiratory symptoms and signs of infection occur. The high prevalence rates of melioidosis in Malaysia warrants better management options to improve quality of life, and life expectancy in patients with CF. Travel activities to endemic regions should also be given more consideration, as this would be crucial to identify and initiate appropriate empiric treatment.

Indexed as

AdolescentAnti-Bacterial AgentsBurkholderia pseudomalleiChronic DiseaseCystic FibrosisDNA, BacterialHumansMalaysiaMaleMelioidosisMultilocus Sequence TypingPneumoniaRecurrenceSputumTomography, X-Ray ComputedAnti-Bacterial AgentsDNA, Bacterial

Identifiers

PMID30185168
PMCPMC6125953
OpenAlexW2890682863

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.